GlassScriptPhysician profile
Dawn Chung
NPI 1306637335
$1,455.20
in general payments reported to CMS, 2019-2025
11 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.55 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $296.62 | 2025 | Nemluvio, Aklief |
| Amgen INC. | $249.00 | 2025 | Otezla |
| Abbvie INC. | $190.17 | 2025 | |
| Janssen Biotech, INC. | $172.77 | 2025 | Tremfya, Simponi, Stelara |
| Regeneron Healthcare Solutions, INC. | $155.93 | 2025 | Dupixent |
| Lilly USA, LLC | $103.44 | 2025 | Ebglyss |
| Genzyme Corporation | $98.70 | 2025 | |
| Leo Pharma INC. | $72.73 | 2025 | Anzupgo |
| Incyte Corporation | $65.44 | 2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $32.11 | 2025 | |
| Organon LLC | $18.29 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.